Susquehanna International Group, LLP Nemaura Medical Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$3.78 - $4.66 $228,312 - $281,464	60,400 Added 188.16%	92,500 $404,000
Q4 2021 Feb 14, 2022	BUY	$4.12 - $6.35 $15,244 - $23,495	3,700 Added 13.03%	32,100 $146,000
Q3 2021 Nov 15, 2021	SELL	$5.76 - $9.95 $176,832 - $305,465	-30,700 Reduced 51.95%	28,400 $171,000
Q2 2021 Aug 11, 2021	BUY	$4.7 - $16.7 $109,510 - $389,110	23,300 Added 65.08%	59,100 $612,000
Q1 2021 May 17, 2021	BUY	$3.79 - $9.78 $135,682 - $350,124	35,800 New	35,800 $274,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.